Guardion Health Sciences, Inc. (NASDAQ:GHSI) Short Interest Update

Guardion Health Sciences, Inc. (NASDAQ:GHSI) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 148,200 shares, a growth of 6.0% from the March 31st total of 139,800 shares. Based on an average daily trading volume, of 210,000 shares, the days-to-cover ratio is currently 0.7 days. Approximately 14.4% of the company’s stock are short sold.

Guardion Health Sciences Price Performance

GHSI opened at $7.92 on Thursday. The company’s 50-day moving average is $8.34 and its 200 day moving average is $6.93. Guardion Health Sciences has a fifty-two week low of $5.01 and a fifty-two week high of $10.75. The firm has a market capitalization of $10.14 million, a P/E ratio of 72.01 and a beta of 0.88.

Guardion Health Sciences (NASDAQ:GHSI) last released its quarterly earnings results on Thursday, March 28th. The company reported $0.33 earnings per share for the quarter. Guardion Health Sciences had a net margin of 0.51% and a return on equity of 2.01%. The company had revenue of $21.56 million for the quarter.

Wall Street Analyst Weigh In

Separately, Maxim Group reiterated a “hold” rating on shares of Guardion Health Sciences in a report on Friday, February 2nd.

About Guardion Health Sciences

Guardion Health Sciences, Inc, a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.